Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 374.2 INR 0.53% Market Closed
Market Cap: 187B INR
Have any thoughts about
Eris Lifesciences Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Eris Lifesciences Ltd

Current Assets 23B
Cash & Short-Term Investments 964.7m
Receivables 4.3B
Other Current Assets 17.8B
Non-Current Assets 47.5B
Long-Term Investments 248.7m
PP&E 5.2B
Intangibles 38.2B
Other Non-Current Assets 3.7B
Current Liabilities 25.3B
Accounts Payable 2.7B
Other Current Liabilities 22.6B
Non-Current Liabilities 19.3B
Long-Term Debt 6.9B
Other Non-Current Liabilities 12.4B

Balance Sheet
Eris Lifesciences Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
50
89
23
106
75
673
369
509
560
942
Cash
50
89
23
106
75
673
369
509
560
942
Short-Term Investments
700
645
902
938
3 149
748
504
995
300
22
Total Receivables
298
349
640
1 135
1 412
2 108
2 189
2 708
4 590
4 276
Accounts Receivables
237
254
489
666
840
1 569
1 345
1 580
2 880
4 220
Other Receivables
61
95
151
469
572
539
844
1 129
1 711
56
Inventory
576
493
583
771
1 112
1 207
1 513
1 798
1 995
1 890
Other Current Assets
11
18
12
37
70
60
96
263
202
15 890
Total Current Assets
1 635
1 593
2 160
2 987
5 818
4 796
4 670
6 273
7 647
23 021
PP&E Net
675
707
558
526
561
873
779
1 919
3 774
5 237
PP&E Gross
675
0
558
526
561
873
779
1 919
3 774
0
Accumulated Depreciation
315
0
208
390
544
577
978
750
934
0
Intangible Assets
7
7
1 382
6 250
6 136
6 985
6 841
6 596
18 806
29 623
Goodwill
36
0
378
935
936
935
935
935
3 318
8 612
Note Receivable
92
149
159
181
154
123
539
71
57
500
Long-Term Investments
973
1 544
2 131
2 716
409
32
2 436
4 208
67
249
Other Long-Term Assets
156
187
499
1 006
1 523
1 780
2 148
2 720
3 004
3 247
Other Assets
36
0
378
935
936
935
935
935
3 318
8 612
Total Assets
3 573
N/A
4 186
+17%
7 267
+74%
14 601
+101%
15 537
+6%
15 523
0%
18 348
+18%
22 721
+24%
36 673
+61%
70 488
+92%
Liabilities
Accounts Payable
367
246
385
908
841
1 001
1 026
1 178
1 248
2 683
Accrued Liabilities
0
0
0
0
0
0
0
0
27
0
Short-Term Debt
24
32
71
3
0
8
0
0
550
0
Current Portion of Long-Term Debt
5
5
2
1 026
1 761
120
23
40
1 383
20 897
Other Current Liabilities
259
407
300
318
452
518
620
779
1 224
1 740
Total Current Liabilities
655
690
758
2 255
3 055
1 647
1 669
1 996
4 432
25 321
Long-Term Debt
5
0
5
2 742
3
61
44
804
6 834
6 915
Deferred Income Tax
0
0
347
523
517
506
495
461
2 576
5 428
Minority Interest
39
32
238
247
183
0
0
1
247
6 359
Other Liabilities
213
256
248
222
273
345
374
378
624
604
Total Liabilities
912
N/A
977
+7%
1 595
+63%
5 988
+275%
4 031
-33%
2 560
-36%
2 584
+1%
3 638
+41%
14 713
+304%
44 627
+203%
Equity
Common Stock
1
1
138
138
138
136
136
136
136
136
Retained Earnings
2 659
3 207
5 534
8 476
11 354
12 828
15 628
18 841
21 673
25 725
Additional Paid In Capital
0
0
0
0
13
0
0
106
151
0
Total Equity
2 660
N/A
3 208
+21%
5 671
+77%
8 613
+52%
11 505
+34%
12 963
+13%
15 764
+22%
19 083
+21%
21 960
+15%
25 861
+18%
Total Liabilities & Equity
3 573
N/A
4 186
+17%
7 267
+74%
14 601
+101%
15 537
+6%
15 523
0%
18 348
+18%
22 721
+24%
36 673
+61%
70 488
+92%
Shares Outstanding
Common Shares Outstanding
138
138
138
138
138
136
136
136
136
136

See Also

Discover More